Latest Market News

Apr 22
Dow’s stock heads for record win streak, is the lone gainer among Dow industrials members

Shares of Dow Inc. DOW, -0.03% rose 0.4% in midday trading, which puts them on track to extend their winning streak to the longest on record. The stock specialty chemical company’s stock is also the lone gainer among components of the Dow Jones Industrial Average DJIA, -1.68%, which tumbled 514 points, or 1.5%. Dow’s stock, […]

Apr 22
Alex Saunders issues a public apology and claims to be settling crypto dealings

Prominent crypto figure Alex Saunders has come back from months of being inactive on social media to issue a public apology for his actions last year. 1416 Total views 15 Total shares Months after a storm of controversies, Nuggets News founder and crypto influencer Alex Saunders issued a public apology over last year’s controversies and […]

Apr 22
LME to end gold and silver futures trading by July: reports

The London Metal Exchange plans to end trading of gold and silver futures by July, citing low levels of trading activity, according to reports on Friday. The LMEprecious service, an initiative created by the LME, the World Gold Council and a group of leading industry players to introduce exchange-traded London precious metals products, is expected […]

Apr 22
Update of the cartography of MiFID activities

Communication FSMA_2022_13 describes the updated MiFID cartography. The new reporting rules will apply as from 30 June 2022 (Communication available in Dutch and French only). Source: FSMA

Apr 22
Emmanuel Macron on crypto: ‘I don’t believe in a self-regulated financial sector’

In an interview, the sitting French president voiced his support for MiCA regulation and the digital euro project. 1967 Total views 30 Total shares Mere days before the second round of the fateful presidential election in France, the incumbent president of the Republic, Emmanuel Macron, sat down with local media to share his thoughts on […]

Apr 22
Biogen stock slides 2% after it withdraws authorization application with EU regulator

Biogen Inc. shares BIIB, -3.21% fell 2% Friday, after the company said it has withdrawn the marketing authorization application for its controversial Alzheimer’s treatment aducanumab with the European regulator because early communications suggest the data is not sufficient to gain a positive opinion. “We stand by the safety and efficacy of aducanumab, and we look […]